Showing results (101-110 of 162) with videos related to
Sort By:
Pageof 17
Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.Current Pharmaceutical Design|October 11, 2016
Effect of Sibutramine on Plasma C-Reactive Protein, Leptin and Adipon ectin Concentrations: A Systematic Review and Meta-Analysis of Randomized Contr olled TrialsAntonio De Vincentis, Claudio Pedone, Umberto Vespasiani-Gentilucci, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.Journal of Clinical Lipidology|January 15, 2013
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat loadGiuseppe Derosa, Arrigo F G Cicero, Elena Fogari, et al.Inflammation|September 11, 2013
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.Internal Medicine (Tokyo, Japan)|October 4, 2013
Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metforminGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.Expert Opinion on Pharmacotherapy|November 6, 2012
Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled studyGiuseppe Derosa, Pietro D Ragonesi, Anna Carbone, et al.Pageof 17